Pulmonx Corporation Announces Management Transition and Preliminary Q3 2025 Revenue

Pulmonx Corporation filed a Form 8-K on October 21, 2025, reporting significant management changes and preliminary financial results for the third quarter of 2025. Steven S. Williamson resigned as President, CEO, and Board member, effective October 27, 2025. He will receive $600,000 over twelve months and COBRA premium reimbursements for up to 14 months. Glendon E. French was appointed as the new President and CEO, effective October 27, 2025. French will receive an annual base salary of $625,000, a target bonus of 100% of his base salary, and equity awards including 1.2 million restricted stock units and 800,000 performance stock units. Mehul Joshi resigned as CFO, effective October 27, 2025, and will receive $347,625 over nine months and COBRA premium reimbursements for up to 11 months. Derrick Sung was appointed as the new COO and CFO, effective November 3, 2025. Sung will receive an annual base salary of $500,000, a target bonus of 60% of his base salary, and equity awards including 1.2 million restricted stock units and 400,000 performance stock units. The company also announced preliminary revenue for Q3 2025, though specific figures were not disclosed.